Back to mobile site

Sangamo Biosciences (SGMO) Tops Q3 EPS by 12c

October 28, 2015 5:34 PM EDT

Sangamo Biosciences (NASDAQ: SGMO) reported Q3 EPS of ($0.13), $0.12 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $8.6 million versus the consensus estimate of $13.09 million.

For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings